aprindine has been researched along with Auricular Fibrillation in 18 studies
Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this study was to evaluate pharmacological cardioversion of long-lasting persistent atrial fibrillation (AF) using bepridil in terms of recovery of atrial mechanical function and maintenance of sinus rhythm." | 9.11 | Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation. ( Fujiki, A; Hirai, T; Inoue, H; Mizumaki, K; Nakagawa, K; Sakabe, M; Tsuneda, T, 2004) |
| "The aim of this study was to investigate the efficacy and safety of bepridil (a multichannel blocker including several potassium channels) for conversion of long-lasting atrial fibrillation (AF)." | 9.10 | Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm. ( Fujiki, A; Inoue, H; Mizumaki, K; Sugao, M; Tsuneda, T, 2003) |
| "A multicenter, placebo-controlled, randomized, double-blind trial compared the preventive effect of aprindine and digoxin on the recurrence of atrial fibrillation (AF) with placebo, and also compare the effectiveness of these 2 drugs in the prevention of AF." | 9.10 | Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation. ( Atarashi, H; Fukunami, M; Hamada, C; Inoue, H; Origasa, H; Sugi, K, 2002) |
| "The relationship between the efficacy of the anticholinergic action of disopyramide, cibenzoline and aprindine and age was examined in patients with paroxysmal and persistent atrial fibrillation." | 7.72 | [Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients]. ( Abe, N; Horiuchi, D; Kameda, K; Komatsu, T; Nakamura, S; Oikawa, K; Okumura, K; Owada, S; Suzuki, O; Tomita, H; Yomogida, K, 2003) |
| "Bepridil alone or in combination with aprindine converted long lasting persistent AF in association with an increase in both FCL and FOI." | 6.71 | Drug-induced changes in fibrillation cycle length and organization index can predict chemical cardioversion of long-lasting atrial fibrillation with bepridil alone or in combination with aprindine. ( Fujiki, A; Inoue, H; Iwamoto, J; Mizumaki, K; Nishida, K; Sakabe, M; Sugao, M; Tsuneda, T, 2004) |
| "The aim of this study was to evaluate pharmacological cardioversion of long-lasting persistent atrial fibrillation (AF) using bepridil in terms of recovery of atrial mechanical function and maintenance of sinus rhythm." | 5.11 | Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation. ( Fujiki, A; Hirai, T; Inoue, H; Mizumaki, K; Nakagawa, K; Sakabe, M; Tsuneda, T, 2004) |
| "The aim of this study was to investigate the efficacy and safety of bepridil (a multichannel blocker including several potassium channels) for conversion of long-lasting atrial fibrillation (AF)." | 5.10 | Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm. ( Fujiki, A; Inoue, H; Mizumaki, K; Sugao, M; Tsuneda, T, 2003) |
| "A multicenter, placebo-controlled, randomized, double-blind trial compared the preventive effect of aprindine and digoxin on the recurrence of atrial fibrillation (AF) with placebo, and also compare the effectiveness of these 2 drugs in the prevention of AF." | 5.10 | Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation. ( Atarashi, H; Fukunami, M; Hamada, C; Inoue, H; Origasa, H; Sugi, K, 2002) |
| "The effects of aprindine on atrial vulnerability were studied in 11 patients; 9 with paroxysmal atrial fibrillation (PAF), and 2 with Wolff-Parkinson-White syndrome, aged 19 to 69 (55." | 5.08 | Effects of aprindine on electrophysiological properties of the atrial muscle in man. ( Centurion, O; Hano, O; Hayano, M; Hirata, T; Isomoto, S; Kaibara, M; Konoe, A; Shimizu, A; Yano, K, 1995) |
| "Bepridil in combination with aprindine could restore sinus rhythm in patients with persistent atrial fibrillation (AF)." | 3.81 | Bepridil enhances aprindine-induced prolongation of atrial effective refractory period in a canine atrial rapid pacing model. ( Fujiki, A; Inoue, H; Kataoka, N; Mizumaki, K; Nakatani, Y; Nishida, K; Sakabe, M; Sakamoto, T; Yamaguchi, Y, 2015) |
| "The relationship between the efficacy of the anticholinergic action of disopyramide, cibenzoline and aprindine and age was examined in patients with paroxysmal and persistent atrial fibrillation." | 3.72 | [Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients]. ( Abe, N; Horiuchi, D; Kameda, K; Komatsu, T; Nakamura, S; Oikawa, K; Okumura, K; Owada, S; Suzuki, O; Tomita, H; Yomogida, K, 2003) |
| "In order to clarify the mechanisms by which the class Ib antiarrhythmic drug aprindine shows efficacy against atrial fibrillation (AF), we examined the effects of the drug on the repolarizing K+ currents in guinea-pig atrial cells by use of patch-clamp techniques." | 3.70 | Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells. ( Nakaya, H; Ohmoto-Sekine, Y; Tamagawa, M; Uemura, H, 1999) |
| "A 73-year-old man had been treated with Aprindine because of paroxysmal atrial fibrillation." | 3.68 | [A case of aprindine-induced pneumonitis]. ( Doutsu, Y; Hara, K; Hayashi, T; Hiratani, K; Hirota, M; Kohno, S; Komori, K; Miyazaki, T; Oda, H; Yamaguchi, K, 1990) |
| "Bepridil alone or in combination with aprindine converted long lasting persistent AF in association with an increase in both FCL and FOI." | 2.71 | Drug-induced changes in fibrillation cycle length and organization index can predict chemical cardioversion of long-lasting atrial fibrillation with bepridil alone or in combination with aprindine. ( Fujiki, A; Inoue, H; Iwamoto, J; Mizumaki, K; Nishida, K; Sakabe, M; Sugao, M; Tsuneda, T, 2004) |
| "The most important arrhythmia is ventricular tachycardia which degenerates to ventricular fibrillation." | 2.43 | [Strategy for cardiac arrhythmias in acute coronary syndrome]. ( Sugi, K, 2006) |
| "Flecainide-induced VF was antagonized by glibenclamide." | 1.29 | Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents. ( Chi, L; Fagbemi, SO; Lucchesi, BR, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (22.22) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 9 (50.00) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakatani, Y | 1 |
| Sakamoto, T | 3 |
| Nishida, K | 4 |
| Kataoka, N | 1 |
| Yamaguchi, Y | 1 |
| Sakabe, M | 3 |
| Fujiki, A | 6 |
| Mizumaki, K | 6 |
| Inoue, H | 7 |
| Shirayama, T | 1 |
| Shiraishi, H | 1 |
| Yoshida, S | 1 |
| Matoba, Y | 1 |
| Imai, H | 1 |
| Nakagawa, M | 1 |
| Komatsu, T | 1 |
| Nakamura, S | 1 |
| Suzuki, O | 1 |
| Yomogida, K | 1 |
| Horiuchi, D | 1 |
| Abe, N | 1 |
| Kameda, K | 1 |
| Owada, S | 1 |
| Tomita, H | 1 |
| Oikawa, K | 1 |
| Okumura, K | 1 |
| Tsuneda, T | 3 |
| Sugao, M | 2 |
| Nakagawa, K | 1 |
| Hirai, T | 1 |
| Iwamoto, J | 2 |
| Sugi, K | 2 |
| Nagasawa, H | 1 |
| Prystowsky, EN | 1 |
| Bauernfeind, RA | 1 |
| Swiryn, SP | 1 |
| Strasberg, B | 1 |
| Palileo, E | 1 |
| Scagliotti, D | 1 |
| Rosen, KM | 2 |
| Wang, HZ | 1 |
| Hano, O | 1 |
| Konoe, A | 1 |
| Hirata, T | 1 |
| Kaibara, M | 1 |
| Isomoto, S | 1 |
| Shimizu, A | 1 |
| Centurion, O | 1 |
| Hayano, M | 1 |
| Yano, K | 1 |
| Fagbemi, SO | 1 |
| Chi, L | 1 |
| Lucchesi, BR | 1 |
| Ohmoto-Sekine, Y | 1 |
| Uemura, H | 1 |
| Tamagawa, M | 1 |
| Nakaya, H | 1 |
| Atarashi, H | 1 |
| Fukunami, M | 1 |
| Hamada, C | 1 |
| Origasa, H | 1 |
| Zipes, DP | 1 |
| Gaum, WE | 1 |
| Foster, PR | 1 |
| Wu, D | 1 |
| Amat-Y-Leon, F | 1 |
| Noble, RJ | 1 |
| Oda, H | 1 |
| Doutsu, Y | 1 |
| Hiratani, K | 1 |
| Miyazaki, T | 1 |
| Komori, K | 1 |
| Hayashi, T | 1 |
| Kohno, S | 1 |
| Yamaguchi, K | 1 |
| Hirota, M | 1 |
| Hara, K | 1 |
2 reviews available for aprindine and Auricular Fibrillation
| Article | Year |
|---|---|
[Strategy for cardiac arrhythmias in acute coronary syndrome].
Topics: Amiodarone; Angina, Unstable; Anti-Asthmatic Agents; Aprindine; Atrial Fibrillation; Bepridil; Elect | 2006 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atr | 1983 |
7 trials available for aprindine and Auricular Fibrillation
| Article | Year |
|---|---|
Usefulness and safety of bepridil in converting persistent atrial fibrillation to sinus rhythm.
Topics: Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Bepridil; Electrocardiography; Female; Heart | 2003 |
Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Atrial Function; Bepridil; Disease-Free Surv | 2004 |
Drug-induced changes in fibrillation cycle length and organization index can predict chemical cardioversion of long-lasting atrial fibrillation with bepridil alone or in combination with aprindine.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Bepridil; Drug Therapy, Combination; E | 2004 |
Pharmacological cardioversion of persistent atrial fibrillation with and without a history of drug-resistant paroxysmal atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Bepridil; Drug Combinations; Drug Resistance | 2006 |
Relation of interleukin-6 and C-reactive protein levels to sinus maintenance after pharmacological cardioversion in persistent atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Bepridil; C-Reactive Protein; Drug The | 2007 |
Effects of aprindine on electrophysiological properties of the atrial muscle in man.
Topics: Action Potentials; Adult; Aged; Aprindine; Atrial Fibrillation; Electrocardiography; Electrophysiolo | 1995 |
Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Coronary Disease; Diabetic Angiopathie | 2002 |
9 other studies available for aprindine and Auricular Fibrillation
| Article | Year |
|---|---|
Bepridil enhances aprindine-induced prolongation of atrial effective refractory period in a canine atrial rapid pacing model.
Topics: Animals; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Atrial Function; Atrial Remodeling; | 2015 |
Atrial fibrillation threshold predicted long-term efficacy of pharmacological treatment of patients without structural heart disease.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Disopyramide; Electrophysiologic Techn | 2002 |
[Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Autonomic Nervous System; Circadian Rh | 2003 |
Electrophysiologic drug testing in prophylaxis of sporadic paroxysmal atrial fibrillation: technique, application, and efficacy in severely symptomatic preexcitation patients.
Topics: Administration, Oral; Adolescent; Adult; Aprindine; Atrial Fibrillation; Cardiac Pacing, Artificial; | 1982 |
[The therapeutic effect of aprindine in treating 9 cases of Wolff-Parkinson-White syndrome associated with auricular fibrillation (author's transl)].
Topics: Adult; Aprindine; Atrial Fibrillation; Female; Humans; Indenes; Male; Middle Aged; Wolff-Parkinson-W | 1982 |
Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Blood Gas A | 1993 |
Inhibitory effects of aprindine on the delayed rectifier K+ current and the muscarinic acetylcholine receptor-operated K+ current in guinea-pig atrial cells.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Atrial Function; | 1999 |
Aprindine for treatment of supraventricular tachycardias. With particular application to Wolff-Parkinson-White syndrome.
Topics: Adult; Aprindine; Atrial Fibrillation; Atrial Flutter; Electrocardiography; Electrophysiology; Femal | 1977 |
[A case of aprindine-induced pneumonitis].
Topics: Aged; Aprindine; Atrial Fibrillation; Humans; Indenes; Male; Pneumonia | 1990 |